Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Kunli Zhu"'
Autor:
Haohua Wang, Xiang Zhang, Boyu Leng, Kunli Zhu, Shumei Jiang, Rui Feng, Xue Dou, Fang Shi, Lei Xu, Jinbo Yue
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-9 (2024)
Abstract Background In locally advanced rectal cancer (LARC), optimizing neoadjuvant strategies, including the addition of concurrent chemotherapy and dose escalation of radiotherapy, is essential to improve tumor regression and subsequent implementa
Externí odkaz:
https://doaj.org/article/d0cd489441e54b52a27332ca16b55966
Autor:
Qingyu Huang, Fuhao Wang, Xiang Zhang, Jing Liu, Xue Dou, Rui Feng, Kunli Zhu, Shumei Jiang, Yun Zhang, Jinbo Yue
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Bile duct obstruction is a common issue for patients with advanced cholangiocarcinoma (CCA). Percutaneous transhepatic cholangial drainage (PTCD) is often required to relieve the obstruction. However, PTCD may alter the intestinal
Externí odkaz:
https://doaj.org/article/ee1cae080d194542a1b0718743a4be34
Publikováno v:
Biochemistry and Biophysics Reports, Vol 34, Iss , Pp 101443- (2023)
Circulating tumor cells (CTCs) are a major cause of tumor metastasis and resistance to anticancer therapies. To date, no effective low-toxicity chemotherapeutic agents or antibodies have exhibited significant clinical activity against CTCs. Macrophag
Externí odkaz:
https://doaj.org/article/c89cbbcda57048e09e4cc673618c5ebf
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background The aim of this study was to investigate the effects of different thoracic radiotherapy doses on OS and incidence of radiation pneumonia which may provide some basis for optimizing the comprehensive treatment scheme of these patie
Externí odkaz:
https://doaj.org/article/605491c8f6ff4cceb3700921180cdf24
Autor:
Qianqian Zhao, Xiaoqing Xu, Jinbo Yue, Kunli Zhu, Rui Feng, Shumei Jiang, Zhonghua Qi, Renben Wang
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 10 (2017)
Background: Peripheral blood lymphocytes play an important role in antitumour immunity. We examined the relationship between the minimum absolute lymphocyte counts (Min ALCs) during radiotherapy (RT) and clinical outcomes in patients with hepatocellu
Externí odkaz:
https://doaj.org/article/458bc1e04cf14eb7b3bcde6899c17407
Autor:
Jing Liu, Benkui Zou, Chao Zhang, Kunli Zhu, Rui Feng, Lei Xu, Xue Dou, Pengyue Shi, Yun Zhang, Jinbo Yue
Publikováno v:
Journal of Clinical Oncology. 41:677-677
677 Background: Although systemic therapy has recently made strides, the 5-year survival rate of mRCC patients is still low — around 10%. Through the abscopal effect, SBRT can improve the antitumor immunity of PD-1 immune checkpoint inhibition (ICI
Publikováno v:
Oncology Letters
The present study aimed to develop two nomograms in order to predict cancer-specific survival (CSS) and overall survival (OS) of patients with anal carcinoma receiving definitive chemoradiotherapy. Data from studies including patients with anal carci
Autor:
Qianqian Zhao1,2, Kunli Zhu2, Jinbo Yue2, Zhonghua Qi1,2, Shumei Jiang2, Xiaoqing Xu2, Rui Feng2, Renben Wang2 wangrenben@sina.cn, Zhao, Qianqian3 (AUTHOR), Zhu, Kunli2 (AUTHOR), Yue, Jinbo2 (AUTHOR), Qi, Zhonghua3 (AUTHOR), Jiang, Shumei2 (AUTHOR), Xu, Xiaoqing2 (AUTHOR), Feng, Rui2 (AUTHOR), Wang, Renben2 (AUTHOR)
Publikováno v:
Therapeutics & Clinical Risk Management. Jan2017, Vol. 13, p21-31. 11p.
Autor:
Kunli Zhu, Yan Zhang, Li Kong, Hongbo Guo, Sujing Liu, Hui Zhu, Wang Jing, Changchun An, Haiyong Wang
Publikováno v:
Future Oncology. 13:1149-1158
Aim: To evaluate the effect of thoracic radiation therapy (TRT) in elderly patients (aged ≥65 years) with extensive-stage small-cell lung cancer (ES-SCLC). Patients & methods: This study reviewed the records of 118 elderly patients with ES-SCLC (al
Autor:
Jinbo Yue, Shumei Jiang, Qianqian Zhao, Zhonghua Qi, Kunli Zhu, Renben Wang, Rui Feng, Xiaoqing Xu
Publikováno v:
Therapeutics and Clinical Risk Management
Qianqian Zhao,1,2 Kunli Zhu,2 Jinbo Yue,2 Zhonghua Qi,1,2 Shumei Jiang,2 Xiaoqing Xu,2 Rui Feng,2 Renben Wang2 1School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, 2Department of Radiation Oncology, Shandon